Veracyte to Present at the 21st Annual Needham Growth Conference
January 09 2019 - 3:30PM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H.
Anderson, chairman and chief executive officer, is scheduled to
present at the 21st Annual Needham Growth Conference in New York
City on Tuesday, January 15, 2019 at 8:40 a.m.
EST (5:40 a.m. PST).
A live audio webcast of the company’s presentation will be
available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcast will be available for 90 days following the conclusion of
the live presentation broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a leading genomic diagnostics company
that improves patient care by providing trustworthy and actionable
answers to challenging clinical questions. The company's products
uniquely combine advanced genomic technology, clinical science and
machine learning to provide answers that give physicians and
patients a clear path forward, informing both diagnosis and
treatment decisions without the need for costly, risky surgeries
that are often unnecessary. Since its founding in 2008,
Veracyte has commercialized three genomic tests, which are
transforming the diagnosis of thyroid cancer, lung cancer and
idiopathic pulmonary fibrosis. Veracyte is based in South San
Francisco, California. For more information, please visit
www.veracyte.com and follow the company on Twitter (@veracyte).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190109005764/en/
Veracyte Media & Investor Contact:Angie McCabeVice
President, Investor Relations & Corporate
Communications650-243-6371angie@veracyte.com
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Apr 2024 to May 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From May 2023 to May 2024